Taken together, these results indicated that the knockdown of CBX8 removes its inhibition on the ITGB4 promoter to increase ITGB4 protein expression, which reduces active RhoA and then results in actin rearrangements that enhance CRC metastasis. This evidence concerns the gene ITGB4 and colorectal carcinoma.